FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dentistry, and can be used for assessing the efficacy of lymphotropic therapy in the maxillofacial region in treating lymphostasis. That is ensured by measuring lymphatic system activity. It involves ultrasonic examination of blood flow velocity in a jugulodigastric lymph node before and after administration of Longidase. If the blood velocity increases ≥0.01 m/s, the lymphotropic therapy is considered to be effective.
EFFECT: invention provides higher accuracy of assessing the effectiveness of lymphotropic therapy.
1 cl, 2 ex
